Quinlan Paul T 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Quinlan Paul T（CIK 1333277）在 1 家公司共报告 17 笔 SEC Form 4 内部人交易（最近一笔 2026-09-21）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-21 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | 买入 | 10,000 | $78,000 |
| 2026-09-21 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | 卖出 | 2,900 | $267,870 |
| 2026-09-21 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | 卖出 | 3,832 | $357,592 |
| 2026-09-21 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | 卖出 | 601 | $56,760 |
| 2026-09-21 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | 卖出 | 2,667 | $254,196 |
| 2026-09-15 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | 卖出 | 1,039 | $99,443 |
| 2026-08-14 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | 买入 | 10,000 | $78,000 |
| 2026-08-14 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | 买入 | 42,000 | $525,000 |
| 2026-08-14 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | 卖出 | 3,630 | $384,963 |
| 2026-08-14 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | 卖出 | 10,434 | $1.1M |
| 2026-08-14 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | 卖出 | 14,696 | $1.6M |
| 2026-08-14 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | 卖出 | 10,200 | $1.1M |
| 2026-08-14 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | 卖出 | 9,193 | $1.0M |
| 2026-08-14 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | 卖出 | 3,847 | $427,547 |
| 2026-06-15 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | 卖出 | 733 | $51,083 |
| 2026-03-17 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | 卖出 | 733 | $30,273 |
| 2026-01-23 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | 买入 | 32,500 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-21